Completely updated and revised, the 32nd edition of this best-selling reference delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It includes detailed descriptions of all antimicrobial agents available today, with complete dosing regimens. New in the 32nd Edition This edition is fully reviewed for updates, and references are updated throughout the book. Highlights of updated or new guidelines include Chapter 5, "Preferred Therapy for Specific Fungal Pathogens": update to candidiasis therapy for systemic infections Chapter 6, "Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins": dosage updates for posaconazole and isavuconazole Chapter 15, "Antimicrobial Prophylaxis/Prevention of Symptomatic Infection": updates to Table A, "Postexposure Antimicrobial Prophylaxis to Prevent Infection": tuberculosis, neonatal herpes simplex virus Table C, "Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection": new information for recurrent mucocutaneous herpes simplex virus Table D, "Surgical Procedure Prophylaxis": intraoperative Re-Dosing interval (h) for prolonged surgery updated throughout; piperacillin/tazobactam therapy added for complicated appendicitis or other ruptured colorectal viscus Chapter 18, Table A, "Systemic Antimicrobials With Dosage Forms and Usual Dosages": now includes Ceftobiprole medocaril sodium, Zevtera Geptotidacin, Blujepa Minocycline ER, Emrosi Paromomycin, Humatin
Debra Palazzi, MD, MEd is Professor of Pediatrics and Division Chief of Pediatric Infectious Diseases at Baylor College of Medicine in Houston, Texas. She is Medical Director of the Antimicrobial Stewardship Program at Texas Children's Hospital and participates in national antimicrobial stewardship educational and research activities. She has a strong interest in medical education and directed or co-directed pediatric infectious diseases fellowship education at Baylor College of Medicine from 2007-2023. She is the Editor of the American Academy of Pediatrics' Pediatric Review and Education Program (PREP) for Infectious Diseases and was a planning committee member, then course co-director, of the PREP ID Review Course for a decade. She is an associate editor for JAMA Pediatrics, one of the leading journals in the world for child health. She has been a member of the Pediatric Infectious Diseases Society (PIDS) Board of Directors since 2017 and currently serves as President Elect. John S. Bradley, MD, FAAP, has been the Medical Director of the Division of Infectious Diseases at Rady Children's Hospital-San Diego since 1988, and is currently Distinguished Professor of Pediatrics, Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego School of Medicine. He has served on the American Academy of Pediatrics Committee on Infectious Diseases (Red Book Committee) 2004-2010, and the Council of the Pediatric Infectious Diseases Society (PIDS) Council, 2007-2011 where he promoted the development of a PIDS Antimicrobial Stewardship program. John D. Nelson, MD is Professor Emeritus of Pediatrics at the University of Texas Southwestern Medical Center and Children's Medical Center, the same institution since he started his career back in 1957. At UT Southwestern he established the first formal Pediatric Infectious Disease fellowship program with Dr. Kenneth Haltalin and later Dr. George McCracken. He also went on to establish the National Pediatric Infectious Disease Seminar with Dr. McCracken and in 1982 they founded the Pediatric Infectious Disease Journal for which they continue as Chief Editors. In 1975 Dr. Nelson produced the first edition of the Pocket Book of Pediatric Antimicrobial Therapy which has gone through 20 biennial editions and is now edited by Dr. John Bradley.
Antimicrobial Therapy According to Clinical Syndromes Antimicrobial Therapy for Neonates Preferred Therapy for Bacterial & Mycobacterial Pathogens Choosing Among Antibiotics Within a Class Preferred Therapy for Fungal Pathogens Choosing Among Antifungal Agents Preferred Therapy for Viral Pathogens Choosing Among Antiviral Agents Preferred Therapy for Parasitic Pathogens Choosing Among Antiparasitic Agents How Antibiotic Dosages Are Determined Approach to Antibiotic Therapy for Drug-Resistant Gram-Negative Bacilli & MRSA Antibiotic Therapy for Children With Obesity Sequential Parenteral-Oral Antibiotic Therapy for Serious Infections Antimicrobial Prophylaxis/Prevention of Symptomatic Infection Approach to Antibiotic Allergies Antibiotic Stewardship Systemic & Topical Antimicrobial Dosing & Dose Forms Appendix: Nomogram for Determining Body Surface Area Reference Index
